RUNX1 |
K562 (myelogenous leukemia) |
24 hours following induction with TPA |
Permissive
Robust
|
Homo sapiens |
GSE24777
...
|
MA0002.2
|
RUNX1 |
differentiated embryonic stem cells |
Runx1+/VE-cadherin+/CD41+ |
Permissive
|
Mus musculus |
GSE29514
...
|
MA0002.2
|
RUNX1 |
differentiated embryonic stem cells |
Runx1+/VE-cadherin-/CD41+ |
Permissive
Robust
|
Mus musculus |
GSE29514
...
|
MA0002.2
|
RUNX1 |
L8057 (megakaryoblastic leukemia) |
50nM TPA |
Permissive
Robust
|
Mus musculus |
GSE33653
...
|
MA0002.2
|
RUNX1 |
dendritic cells |
LPS, 0 min |
Permissive
Robust
|
Mus musculus |
GSE36099
...
|
MA0002.2
|
RUNX1 |
dendritic cells |
LPS, 120 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0002.2
|
RUNX1 |
dendritic cells |
LPS, 60 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0002.2
|
RUNX1 |
hematopoietic cells |
dox |
Permissive
Robust
|
Mus musculus |
GSE40235
...
|
MA0002.2
|
RUNX1 |
embryonic stem cell-derived myeloid progenitors |
induced |
Permissive
Robust
|
Mus musculus |
GSE64589
...
|
MA0002.2
|
RUNX1 |
CD4+ T-cells |
PMA 120 min |
Permissive
|
Mus musculus |
GSE67443
...
|
MA0002.2
|
RUNX1 |
embryonic stem cell-derived hematopoietic progenitors |
none |
Permissive
Robust
|
Mus musculus |
GSE69099
...
|
MA0002.2
|
RUNX1 |
embryonic stem cell-derived macrophages |
none |
Permissive
Robust
|
Mus musculus |
GSE69099
...
|
MA0002.2
|
RUNX1 |
FDC-P1 (lymphoblasts) |
RUNX-ERt2 |
Permissive
Robust
|
Mus musculus |
GSE81179
...
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
MEIS2 KD |
Permissive
Robust
|
Homo sapiens |
GSE81321
...
|
MA0002.2
|
RUNX1 |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
RUNX1-EVI1 KD after 10 days |
Permissive
Robust
|
Homo sapiens |
GSE87283
...
|
MA0002.2
|
RUNX1 |
bone marrow |
Untreated |
Permissive
Robust
|
Mus musculus |
GSE87623
...
|
MA0002.2
|
RUNX1 |
bone marrow |
Vitamin C |
Permissive
Robust
|
Mus musculus |
GSE87623
...
|
MA0002.2
|
RUNX1 |
ME-1 (acute myeloid leukemia ) |
Treatment: DMSO for 6 hr; CellType: human inv(16) leukemia cell line; |
Permissive
Robust
|
Homo sapiens |
GSE101789
...
|
MA0002.2
|
RUNX1 |
ME-1 (acute myeloid leukemia ) |
Treatment: Al-10-49 (1uM) for 6 hr; CellType: human inv(16) leukemia cell line; |
Permissive
Robust
|
Homo sapiens |
GSE101789
...
|
MA0002.2
|
RUNX1 |
KP66(mouse sleen cells) |
Genotype: gfil1 KO; |
Permissive
Robust
|
Mus musculus |
GSE103255
...
|
MA0002.2
|
RUNX1 |
WT132(mouse spleen) |
Genotype: wildtype gfi1; |
Permissive
|
Mus musculus |
GSE103255
...
|
MA0002.2
|
RUNX1 |
HEE (human epididymis epithelial cells) |
Treatment: without treatment of R1881 (methyltrienolone) |
Permissive
|
Homo sapiens |
GSE109061
...
|
MA0002.2
|
RUNX1 |
HEE (human epididymis epithelial cells) |
Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr |
Permissive
Robust
|
Homo sapiens |
GSE109061
...
|
MA0002.2
|
RUNX1 |
HEE (human epididymis epithelial cells) |
Treatment: without treatment of R1881 (methyltrienolone) |
Permissive
|
Homo sapiens |
GSE109061
...
|
MA0002.2
|
RUNX1 |
HEE (human epididymis epithelial cells) |
Treatment: treatment of 1 nM R1881 (methyltrienolone) for 12 -16 hr |
Permissive
|
Homo sapiens |
GSE109061
...
|
MA0002.2
|
RUNX1 |
NALM-6 (adult B acute lymphoblastic leukemia) |
Tissue: Peripheral blood |
Permissive
Robust
|
Homo sapiens |
GSE109377
...
|
MA0002.2
|
RUNX1 |
NALM-6 (adult B acute lymphoblastic leukemia) |
Tissue: Peripheral blood |
Permissive
Robust
|
Homo sapiens |
GSE109377
...
|
MA0002.2
|
RUNX1 |
pre-B-lymphoblast cells with BCP-ALL |
DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow |
Permissive
Robust
|
Homo sapiens |
GSE109377
...
|
MA0002.2
|
RUNX1 |
pre-B-lymphoblast cells with BCP-ALL |
DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow |
Permissive
Robust
|
Homo sapiens |
GSE109377
...
|
MA0002.2
|
RUNX1 |
pre-B-lymphoblast cells with BCP-ALL |
DIsease: human precursor leukemia (BCP-ALL) Tissue: bone marrow |
Permissive
Robust
|
Homo sapiens |
GSE109377
...
|
MA0002.2
|
RUNX1 |
pre- leukemia stem cells (CD34+ human cord blood cells) |
Treatment: untreated |
Permissive
|
Homo sapiens |
GSE80773
...
|
MA0002.2
|
RUNX1 |
Lin- BM derived DN1 cells |
Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow |
Permissive
|
Mus musculus |
GSE103953
...
|
MA0002.2
|
RUNX1 |
Lin- BM derived DN1 cells |
Genotype: Lin-, CD45+, Kit+,CD25- Strain: C57BL6/J Treatmen: Cultured on OP9DL1 Tissue: bone marrow |
Permissive
|
Mus musculus |
GSE103953
...
|
MA0002.2
|
RUNX1 |
Lin- BM derived DN3 cells |
Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+ |
Permissive
Robust
|
Mus musculus |
GSE103953
...
|
MA0002.2
|
RUNX1 |
Lin- BM derived DN3 cells |
Strain: C57BL6/J Treatment: Cultured on OP9DL1 Genotype: Lin-CD45+Kit-CD25+ |
Permissive
Robust
|
Mus musculus |
GSE103953
...
|
MA0002.2
|
RUNX1 |
hemogenic endothelium |
Strain: 129P2/OlaHsd Treatment: untreated, no DOX, uniduced |
Permissive
|
Mus musculus |
GSE104045
...
|
MA0002.2
|
RUNX1 |
hemogenic endothelium |
Strain: 129P2/OlaHsd Treatment: induced by treatment with DOX |
Permissive
Robust
|
Mus musculus |
GSE104045
...
|
MA0002.2
|
RUNX1 |
hemogenic endothelium |
Strain: 129P2/OlaHsd Treatment: JQ1, induced by treatment with DOX |
Permissive
Robust
|
Mus musculus |
GSE104045
...
|
MA0002.2
|
RUNX1 |
lin-bone marrow |
Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 |
Permissive
Robust
|
Mus musculus |
GSE110305
...
|
MA0002.2
|
RUNX1 |
lin-bone marrow |
Strain: C57BL6/J Genotype: wildtype DN3 Treatment: cultured on OP9DL1 |
Permissive
Robust
|
Mus musculus |
GSE110305
...
|
MA0002.2
|
RUNX1 |
lin-bone marrow |
Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 |
Permissive
Robust
|
Mus musculus |
GSE110305
...
|
MA0002.2
|
RUNX1 |
lin-bone marrow |
Strain: C57BL6/J Genotype: Bcl11b knockout DN3 Treatment: cultured on OP9DL1 |
Permissive
Robust
|
Mus musculus |
GSE110305
...
|
MA0002.2
|
RUNX1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; C57BL/6J strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0002.2
|
RUNX1 |
BMDM (bone marrow-derived macrophages) |
C57BL/6J strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0002.2
|
RUNX1 |
EML -C1(EML, clone 1) |
Passage: 4-5 Strain: C57BL/6 |
Permissive
Robust
|
Mus musculus |
GSE75186
...
|
MA0002.2
|
RUNX1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-Mock-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0002.2
|
RUNX1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-Mock-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0002.2
|
RUNX1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0002.2
|
RUNX1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0002.2
|
RUNX1 |
Dombi23 (primary keratinocytes) |
day 0 of differentiation |
Permissive
|
Homo sapiens |
GSE98483
...
|
MA0002.2
|
RUNX1 |
ILC2 (type 2 Innate lympoid cells) |
Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung |
Permissive
Robust
|
Mus musculus |
GSE111871
...
|
MA0002.2
|
RUNX1 |
TF-1 (erythroleukemia) |
Genotype: wildtype; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0002.2
|
RUNX1 |
TF-1 (erythroleukemia) |
Genotype: wildtype; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0002.2
|
RUNX1 |
TF-1 (erythroleukemia) |
Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; |
Permissive
Robust
|
Homo sapiens |
GSE73207
...
|
MA0002.2
|
RUNX1 |
myeloid cell |
Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant; |
Permissive
|
Homo sapiens |
GSE111821
...
|
MA0002.2
|
RUNX1 |
myeloid cell |
Sex: male; Tissue: Venous blood; Age: 45-50; Genotype: RUNX1 mutant; |
Permissive
|
Homo sapiens |
GSE111821
...
|
MA0002.2
|
RUNX1 |
myeloid cell |
Sex: male; Tissue: Bone marrow; Age: 55-60; Genotype: RUNX1 mutant; |
Permissive
|
Homo sapiens |
GSE111821
...
|
MA0002.2
|
RUNX1 |
myeloid cell |
Sex: male; Tissue: Venous blood; Age: 65-70; Genotype: RUNX1 mutant; |
Permissive
|
Homo sapiens |
GSE111821
...
|
MA0002.2
|
RUNX1 |
cord blood CD34 cells |
Genotype: control; |
Permissive
|
Homo sapiens |
GSE111917
...
|
MA0002.2
|
RUNX1 |
cord blood CD34 cells |
Genotype: RUNX1mut transduced; |
Permissive
Robust
|
Homo sapiens |
GSE111917
...
|
MA0002.2
|
RUNX1 |
iPSC (induced pluripotent stem cells) |
Characteristic: harvest time 31 day;Genotype: control; |
Permissive
|
Homo sapiens |
GSE111917
...
|
MA0002.2
|
RUNX1 |
iPSC (induced pluripotent stem cells) |
Characteristic: harvest time 31 day; Treatment: dox; Genotype: DOX-induced RUNX1mut; |
Permissive
|
Homo sapiens |
GSE111917
...
|
MA0002.2
|
RUNX1 |
iPSC (induced pluripotent stem cells) |
Characteristic: harvest time 34 day; Genotype: control; |
Permissive
|
Homo sapiens |
GSE111917
...
|
MA0002.2
|
RUNX1 |
iPSC (induced pluripotent stem cells) |
Characteristic: harvest time 34 day; Treatment: dox; Genotype: DOX-induced RUNX1mut; |
Permissive
|
Homo sapiens |
GSE111917
...
|
MA0002.2
|
RUNX1 |
ME-1 (acute myeloid leukemia ) |
Treatment: no dox; Genotype: CBFB-MYH11 knockdown construct, RUNX1 wildtype; |
Permissive
Robust
|
Homo sapiens |
GSE117138
...
|
MA0002.2
|
RUNX1 |
ME-1 (acute myeloid leukemia ) |
Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, RUNX1 knockdown; |
Permissive
Robust
|
Homo sapiens |
GSE117138
...
|
MA0002.2
|
RUNX1 |
fetal ovary |
Sex: Female; Developmental stage: E14.5; Strain: CD1; |
Permissive
Robust
|
Mus musculus |
GSE128767
...
|
MA0002.2
|
RUNX1 |
fetal ovary |
Sex: Female; Developmental stage: E14.5; Strain: CD1; |
Permissive
|
Mus musculus |
GSE128767
...
|
MA0002.2
|
RUNX1 |
primary neurofibroma cells |
Genotype: Nf1fl/fl(knockout),DhhCre; Strain: C57BL/6-I129; Treatment: shRNA; |
Permissive
Robust
|
Mus musculus |
GSE122775
...
|
MA0002.2
|
RUNX1 |
VCaP (prostate carcinoma) |
DHT24H |
Permissive
|
Homo sapiens |
GSE58428
|
MA0002.2
|
RUNX1 |
|
MARROW |
Permissive
Robust
|
Homo sapiens |
GSE64862
|
MA0002.2
|
RUNX1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR414TYY
|
MA0002.2
|
RUNX1 |
K562 (myelogenous leukemia) |
|
Permissive
|
Homo sapiens |
ENCSR588AKU
|
MA0002.2
|
RUNX1 |
Jurkat E6.1 (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE17954
...
|
MA0002.2
|
RUNX1 |
embryonic stem cell-derived haematopoietic cells |
|
Permissive
Robust
|
Mus musculus |
GSE22178
...
|
MA0002.2
|
RUNX1 |
megakaryocytes |
|
Permissive
Robust
|
Homo sapiens |
GSE24674
...
|
MA0002.2
|
RUNX1 |
CMK (acute megakaryoblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE24777
...
|
MA0002.2
|
RUNX1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE24777
...
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE29222
...
|
MA0002.2
|
RUNX1 |
Lin- SCA+ CD34+ hematopoietic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE31221
...
|
MA0002.2
|
RUNX1 |
L8057 (megakaryoblastic leukemia) |
|
Permissive
Robust
|
Mus musculus |
GSE33653
...
|
MA0002.2
|
RUNX1 |
thymocytes |
|
Permissive
Robust
|
Mus musculus |
GSE33653
...
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE34540
...
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE34540
...
|
MA0002.2
|
RUNX1 |
hematopoietic cells |
|
Permissive
Robust
|
Mus musculus |
GSE40235
...
|
MA0002.2
|
RUNX1 |
CD34+ hematopoietic stem cells |
|
Permissive
Robust
|
Homo sapiens |
GSE45144
...
|
MA0002.2
|
RUNX1 |
megakaryocytes |
|
Permissive
Robust
|
Mus musculus |
GSE45372
...
|
MA0002.2
|
RUNX1 |
BMiFLT3(15-3) (murine acute lymphoblastic leukemia) |
|
Permissive
Robust
|
Mus musculus |
GSE45377
...
|
MA0002.2
|
RUNX1 |
CD4+ CD25+ CD45RA+ T-cells |
|
Permissive
|
Homo sapiens |
GSE43119
...
|
MA0002.2
|
RUNX1 |
CD4+ CD25- T-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE43119
...
|
MA0002.2
|
RUNX1 |
CD4+ CD25- T-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE43119
...
|
MA0002.2
|
RUNX1 |
mast cells |
|
Permissive
Robust
|
Mus musculus |
GSE48085
...
|
MA0002.2
|
RUNX1 |
mature megakaryocytes |
|
Permissive
|
Mus musculus |
GSE42108
...
|
MA0002.2
|
RUNX1 |
myoblasts |
|
Permissive
Robust
|
Mus musculus |
GSE56077
...
|
MA0002.2
|
RUNX1 |
EML -C1(EML, clone 1) |
|
Permissive
Robust
|
Mus musculus |
GSE62596
...
|
MA0002.2
|
RUNX1 |
embryonic stem cell-derived myeloid progenitors |
|
Permissive
|
Mus musculus |
GSE64589
...
|
MA0002.2
|
RUNX1 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE67443
...
|
MA0002.2
|
RUNX1 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE67443
...
|
MA0002.2
|
RUNX1 |
FDC-P1 (lymphoblasts) |
|
Permissive
Robust
|
Mus musculus |
GSE81179
...
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE81321
...
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
|
Homo sapiens |
GSE76464
...
|
MA0002.2
|
RUNX1 |
MV-4-11 (Childhood acute monocytic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE79899
...
|
MA0002.2
|
RUNX1 |
THP-1 (acute monocytic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE79899
...
|
MA0002.2
|
RUNX1 |
NB4 (acute promyelocytic leukemia ) |
|
Permissive
Robust
|
Homo sapiens |
GSE81992
...
|
MA0002.2
|
RUNX1 |
Hoxb8-FL |
|
Permissive
Robust
|
Mus musculus |
GSE84328
...
|
MA0002.2
|
RUNX1 |
Jurkat (T-cells) |
|
Permissive
|
Homo sapiens |
GSE85524
...
|
MA0002.2
|
RUNX1 |
HEK293T (embryonic kidney) |
|
Permissive
|
Homo sapiens |
GSE85524
...
|
MA0002.2
|
RUNX1 |
peripheral blood mononuclear cells |
|
Permissive
Robust
|
Homo sapiens |
GSE85524
...
|
MA0002.2
|
RUNX1 |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
|
Permissive
Robust
|
Homo sapiens |
GSE87283
...
|
MA0002.2
|
RUNX1 |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
|
Permissive
Robust
|
Homo sapiens |
GSE87283
...
|
MA0002.2
|
RUNX1 |
embryonic fibroblasts |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0002.2
|
RUNX1 |
embryonic fibroblasts expressing OSKM for 48h |
|
Permissive
|
Mus musculus |
GSE90893
...
|
MA0002.2
|
RUNX1 |
natural killer T cells |
|
Permissive
Robust
|
Mus musculus |
GSE98662
...
|
MA0002.2
|
RUNX1 |
HL-60 (acute myeloid leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE107553
...
|
MA0002.2
|
RUNX1 |
LPS141 (Dedifferentiated liposarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE111253
...
|
MA0002.2
|
RUNX1 |
HL-60 (acute myeloid leukemia) |
|
Permissive
|
Homo sapiens |
ERP008568
|
MA0002.2
|
RUNX1 |
SKNO-1 (acute myeloid leukemia) |
|
Permissive
|
Homo sapiens |
GSE23730
|
MA0002.2
|
RUNX1 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE29180
|
MA0002.2
|
RUNX1 |
CCRF-CEM (T acute lymphoblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE33850
|
MA0002.2
|
RUNX1 |
|
|
Permissive
Robust
|
Homo sapiens |
GSE42075
|
MA0002.2
|
RUNX1 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE42575
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE45738
|
MA0002.2
|
RUNX1 |
ME-1 (acute myeloid leukemia ) |
|
Permissive
Robust
|
Homo sapiens |
GSE46044
|
MA0002.2
|
RUNX1 |
|
|
Permissive
|
Homo sapiens |
GSE60130
|
MA0002.2
|
RUNX1 |
TSU-1621-MT (adult acute myeloid leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE60477
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE62847
|
MA0002.2
|
RUNX1 |
CD34+ cells |
|
Permissive
Robust
|
Homo sapiens |
GSE64862
|
MA0002.2
|
RUNX1 |
|
|
Permissive
Robust
|
Homo sapiens |
GSE65313
|
MA0002.2
|
RUNX1 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE65427
|
MA0002.2
|
RUNX1 |
U937 (adult acute monocytic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE65427
|
MA0002.2
|
RUNX1 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE68976
|
MA0002.2
|
RUNX1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE75070
|
MA0002.2
|
RUNX1 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE76181
|
MA0002.2
|
RUNX1 |
CD34+ cells |
ADULT |
Permissive
Robust
|
Homo sapiens |
GSE70660
|
MA0002.2
|
RUNX1 |
CD34+ cells |
FETAL |
Permissive
Robust
|
Homo sapiens |
GSE70660
|
MA0002.2
|